Spots Global Cancer Trial Database for tadalafil
Every month we try and update this database with for tadalafil cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
---|---|---|---|---|---|---|
A Study to Assess the Efficacy of Tadalafil to Treat Erectile Dysfunction After Radiotherapy of Prostate Cancer | NCT00122499 | Prostate Cancer Erectile Dysfun... | tadalafil | 18 Years - | Erasmus Medical Center | |
PDE5 Inhibition Via Tadalafil to Enhance Anti-Tumor Mucin 1 (MUC1) Vaccine Efficacy in Patients With HNSCC | NCT02544880 | Head and Neck S... Head and Neck C... | Tadalafil Anti-MUC1 Vacci... Anti-Influenza ... Tadalafil Place... Anti-MUC1 Vacci... Standard of Car... Anti-Influenza ... | 18 Years - | University of Miami | |
Study of CRS-207, Pembrolizumab, Ipilimumab, and Tadalafil in Metastatic Pancreatic Cancer | NCT05014776 | Pancreatic Canc... | Tadalafil Pembrolizumab Ipilimumab CRS-207 | 18 Years - | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | |
Tadalafil to Overcome Immunosuppression During Chemoradiotherapy for IDH-wildtype Grade III-IV Astrocytoma | NCT04757662 | Grade III Astro... Grade IV Astroc... Astrocytoma, Gr... Astrocytoma, Gr... | Tadalafil | 18 Years - | Washington University School of Medicine | |
Marrow Infiltrating Lymphocytes - Non-Small Cell Lung Cancer (MILs™ - NSCLC) Alone or in Combination With Nivolumab With or Without Tadalafil in Locally Advanced and Unresectable or Metastatic NSCLC | NCT04069936 | Non Small Cell ... Lung Cancer Lung Cancer Met... Lung Cancer, No... Non Small Cell ... NSCLC Non-small Cell ... Non-small Cell ... | MILs™ - NSCLC nivolumab tadalafil | 18 Years - | WindMIL Therapeutics | |
A Trial of Tadalafil in Patients With Squamous Cell Carcinoma of the Upper Aero Digestive Tract | NCT00894413 | Head and Neck S... | Tadalafil Placebo Pill | 18 Years - 99 Years | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | |
Tadalafil and Pembrolizumab in Recurrent or Metastatic Head and Neck Cancer | NCT03993353 | Head and Neck C... Head and Neck S... Head and Neck C... Head and Neck C... Head and Neck C... Head and Neck C... Cancer Cancer of Esoph... Cancer, Metasta... Cancer of Head ... Cancer of Mouth Cancer of Neck | Pembrolizumab Tadalafil | 18 Years - | University of California, San Diego | |
A Phase II Trial of Tadalafil in Patients With Squamous Cell Carcinoma of the Upper Aero Digestive Tract | NCT01697800 | Head and Neck S... | Tadalafil Placebo | 21 Years - 99 Years | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | |
Window of Opportunity Trial of Nivolumab and Tadalafil in Patients With Squamous Cell Carcinoma of the Head and Neck | NCT03238365 | Lip, Oral Cavit... Larynx | Nivolumab Tadalafil Therapeutic Con... | 18 Years - | Thomas Jefferson University | |
Chemoimmunotherapy and Radiation in Pancreatic Cancer | NCT01903083 | Locally Advance... | Tadalafil Gemcitabine Radiation Pancreaticoduod... | 18 Years - | Providence Health & Services | |
Tadalafil in Preventing Erectile Dysfunction in Patients With Prostate Cancer Treated With Radiation Therapy | NCT00931528 | Prostate Cancer Sexual Dysfunct... | Tadalafil Placebo | 18 Years - 120 Years | Radiation Therapy Oncology Group | |
Tadalafil to Overcome Immunosuppression During Chemoradiotherapy for IDH-wildtype Grade III-IV Astrocytoma | NCT04757662 | Grade III Astro... Grade IV Astroc... Astrocytoma, Gr... Astrocytoma, Gr... | Tadalafil | 18 Years - | Washington University School of Medicine | |
A Trial of Tadalafil in Patients With Squamous Cell Carcinoma of the Upper Aero Digestive Tract | NCT00894413 | Head and Neck S... | Tadalafil Placebo Pill | 18 Years - 99 Years | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | |
PDE5 Inhibition Via Tadalafil to Enhance Anti-Tumor Mucin 1 (MUC1) Vaccine Efficacy in Patients With HNSCC | NCT02544880 | Head and Neck S... Head and Neck C... | Tadalafil Anti-MUC1 Vacci... Anti-Influenza ... Tadalafil Place... Anti-MUC1 Vacci... Standard of Car... Anti-Influenza ... | 18 Years - | University of Miami | |
Can Tadalafil Maintain Erectile Function In Patients Treated With Radiotherapy For Prostate Cancer? | NCT00215631 | Prostate Cancer Erectile Dysfun... | tadalafil | 18 Years - | Erasmus Medical Center | |
Marrow Infiltrating Lymphocytes - Non-Small Cell Lung Cancer (MILs™ - NSCLC) Alone or in Combination With Nivolumab With or Without Tadalafil in Locally Advanced and Unresectable or Metastatic NSCLC | NCT04069936 | Non Small Cell ... Lung Cancer Lung Cancer Met... Lung Cancer, No... Non Small Cell ... NSCLC Non-small Cell ... Non-small Cell ... | MILs™ - NSCLC nivolumab tadalafil | 18 Years - | WindMIL Therapeutics |